Forth
Forth is a UK direct-to-consumer medtech company operating an at-home blood testing platform across 70+ tests (hormones, fertility, cancer screening, wellness), with samples processed in NHS-accredited labs and results delivered via its HealthCoach mobile app.
- Company typePrivate
- Founded2016
- HeadquartersChepstow, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Forth does
Forth (legally Humankind Ventures Ltd.) is a Wales-based direct-to-consumer medtech company that operates an at-home blood testing platform. The company sells more than 70 finger-prick and venous blood test kits across hormones, fertility, menopause, nutrition, general wellness, sexual health, sports performance, and cancer screening, with samples processed in NHS- and UKAS-accredited laboratories and results delivered through a proprietary iOS/Android HealthCoach application that converts biomarkers into health scores and personalised targets. The flagship technology, MyFORM, uses two timed blood samples (day 14 and day 21 of the menstrual cycle) combined with algorithmic mathematical modelling to map fluctuations of four reproductive hormones across the menstrual cycle, a capability Forth positions as unique in the UK home-testing market. A second proprietary line, TruCheck, offers multi-cancer screening via circulating tumour cell detection across 70+ cancer types, validated on 40,000+ participants.
The business model is direct-to-consumer e-commerce with one-time, pay-as-you-go test purchases ranging from £39 (bespoke single-marker builds) to £1,169 (TruCheck), supplemented by Klarna instalments, an AutoDraw add-on device (£20), and paid phlebotomy services (£45 partner clinic or £59 home nurse). Distribution runs through the company website, mobile app, a network of 270+ UK partner clinics, and mobile phlebotomists; a B2B channel, ForthConnect (forthconnect.io), sells the same testing platform into corporate wellness programs. Customer reach is reported at 60,000+ customers and 800,000+ to 1,000,000+ results delivered cumulatively, with the primary segments being women seeking hormone/perimenopause insights, athletes, and proactive health consumers. To date the company has disclosed approximately £1.6M in funding (November 2021) led by Trajan Scientific and Medical and the Development Bank of Wales, alongside earlier Development Bank of Wales rounds, and holds ISO 15189, 13485, 27001, and 9001 certifications with an MHRA Class I SaMD registration for MyFORM.
Forth firmographics
Firmographics- Name
- Forth
- Legal name
- Humankind Ventures Ltd.
- Website
- https://forthwithlife.co.uk
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Forth is a UK direct-to-consumer medtech company operating an at-home blood testing platform across 70+ tests (hormones, fertility, cancer screening, wellness), with samples processed in NHS-accredited labs and results delivered via its HealthCoach mobile app.
- Ownership category
- akta.pro rank
Forth industry classification
Industry- Product category
- Direct-to-consumer at-home blood testing
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Health and Personal Care Retailers (456)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
- akta.pro secondary industries
- Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)
Keywords
Where Forth is headquartered
LocationHeadquarters
- HQ city
- Chepstow
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Forth business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Direct-to-Consumer Blood Tests: One-time purchase of individual blood test kits ranging from basic single-marker tests to comprehensive health panels. Customers purchase through the e-commerce website and ForthConnect business platform. Tests include finger-prick home kits, AutoDraw device options, and venous blood draw arrangements.
- TruCheck Cancer Screening: Premium-priced comprehensive cancer screening test at £1,169, requiring pre-test screening call with doctor and venous blood draw by medical professional.
- Bespoke Test Builder: Customizable test builder allowing customers to select specific biomarkers for personalized testing, starting from £39.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Baseline Blood Test - Essential health markers |
| One time/ perpetual license | Pay-as-you-go | Advanced Health Check - Expanded insights |
| One time/ perpetual license | Pay-as-you-go | Ultimate Health Check - Most comprehensive analysis |
| One time/ perpetual license | Pay-as-you-go | TruCheck Cancer Screening - 70+ cancer types |
| Unit Pricing | Pay-as-you-go | Female Hormone Imbalance Test |
| Unit Pricing | Pay-as-you-go | MyFORM Perimenopause Test |
| Unit Pricing | Pay-as-you-go | Personalised/Bespoke Test Builder |
| Unit Pricing | Pay-as-you-go | Male Hormone Blood Test |
| Unit Pricing | Pay-as-you-go | Home Nurse/Phlebotomy Service |
| Unit Pricing | Pay-as-you-go | Partner Clinic Blood Draw |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Forth product offering
Product offeringCore offering
Forth operates a direct-to-consumer home blood testing platform selling fingerprick and venous blood sample collection kits spanning female hormones, general wellness, nutrition, sexual health, sports performance, and cancer screening. Samples are analysed by UKAS-accredited laboratories and results are delivered through the HealthCoach mobile app with health scores and personalised recommendations, plus optional home phlebotomy and a 270+ partner-clinic network. A separate ForthConnect B2B channel serves corporate wellness programs.
Product overview
Forth is a health monitoring platform offering at-home blood testing services. The core offering is a direct-to-consumer home blood testing platform with fingerprick and venous collection options, NHS-accredited laboratory analysis, and a mobile app delivering personalized health scores and doctor-reviewed results. The product portfolio spans hormone testing (including flagship MyFORM® hormone mapping technology), general health checks, nutrition, sexual health, cancer screening (TruCheck™), and sports performance tests. Users can choose from 70+ pre-configured tests or build custom panels via the bespoke test builder. The platform includes the HealthCoach app providing AI-driven personalized health targets and recommendations. A B2B offering (Forth Connect) serves enterprise employee wellness programs.
Differentiator
Problem solved
Functional benefit
Brands
- MyFORM: Ground-breaking hormone mapping technology for female hormone testing including perimenopause detection and hormone cycle mapping.
- TruCheck
- Forth Connect
Products and services
- Forth Home Blood Tests Platform Forth's core D2C home blood testing platform offering fingerprick and venous blood sample collection with NHS/UKAS-accredited laboratory analysis, delivering doctor-reviewed results, personalised health scores and recommendations through the HealthCoach app, plus optional home phlebotomy and a 270+ partner-clinic network across the UK.
- MyFORM® Perimenopause Test Ground-breaking hormone-mapping test using two blood samples (day 14 and day 21 of the menstrual cycle) combined with AI-driven mathematical modelling to map all four key reproductive hormones across the entire cycle and identify perimenopause patterns; the only at-home UK blood test positioned to detect perimenopause patterns, £139 for 40 biomarkers.
- MyFORM® Female Hormone Mapping Maps all four key reproductive hormones across the menstrual cycle using two timed blood samples and algorithmic mathematical modelling to produce personalised hormone graphs for women tracking fertility, perimenopause or general cycle health.
- Female Hormone Imbalance Test Single-day female hormone test measuring 11 biomarkers including FSH, LH, oestradiol, progesterone, prolactin, testosterone, SHBG, Free Androgen Index, and thyroid hormones (TSH, T4, T3); used by women assessing hormonal balance, fertility, PCOS and menopause; £89.
- Male Hormone Blood Test Comprehensive male hormone test measuring testosterone, oestrogen and other biomarkers linked to energy, mood, body composition and sexual health, rated 4.5/5 from 137 reviews.
- Female Fertility Test Fertility-focused test checking AMH, FSH, LH, oestrogen, progesterone, prolactin and thyroid hormones to assess ovulation and hormonal balance for women trying to conceive.
- AMH (Anti-Mullerian Hormone) Test Single-biomarker test measuring ovarian reserve via anti-Mullerian hormone (AMH), useful for women considering starting a family later or undergoing IVF treatment.
- Menopause Health Test Comprehensive test for post-menopausal women checking oestrogen and progesterone alongside biomarkers for bone strength and heart health; also suitable for monitoring HRT effectiveness.
- PCOS (PMOS) Home Blood Test Kit Measures six biomarkers (AMH, testosterone, LH, FSH, oestradiol, prolactin) plus metabolic markers most closely linked to Polycystic Ovary Syndrome / Polyendocrine Metabolic Ovarian Syndrome.
- Progesterone Blood Test Day-21 ovulation confirmation test measuring progesterone levels to determine if ovulation has occurred; targeted at women trying to conceive.
- Oestradiol Blood Test Single-biomarker test for tracking oestradiol (oestrogen) levels related to fertility, menopause and hormonal disorders such as PCOS.
- PSA (Prostate-Specific Antigen) Test PSA blood test introduced for men aged 45 and over to check for raised prostate-specific antigen levels as an indicator of prostate health risk.
- TruCheck™ Early Cancer Screening Test Multi-cancer screening blood test using circulating tumour cell (CTC) detection to screen for over 70 cancer types; validated on 40,000+ participants with 88% sensitivity and 96% accuracy in determining tissue/organ of origin; £1,169 including screening call with a doctor and venous blood draw.
- Baseline Health Check Entry-level wellness blood test covering 23 biomarkers across energy, immune health, heart health, liver function and nutrition including vitamin D, ferritin and B12; £135.
- Advanced Health Check Mid-tier comprehensive blood test with 47 biomarkers covering bone health, heart, liver, thyroid function, energy levels, nutrition, immune and hormone health; £167.
- Ultimate Health Check Most comprehensive Forth panel with 70 biomarkers, including everything in Advanced Health Check plus thyroid antibodies, electrolytes, Omega-6 to Omega-3 ratio, and antioxidant vitamins (Vitamin A and E); £399 with results in 15 working days.
- STI Home Test Kits At-home sexual health testing across three tiers: Basic (Chlamydia, Gonorrhoea), Standard (adds HIV, Syphilis) and Comprehensive (adds Hepatitis B and C); all CE-marked and analysed in UKAS-accredited laboratories.
- Sports Blood Tests Specialised blood test category for athletes including Male Fitness, Female Fitness and Advanced Female Athlete (RED-S / Relative Energy Deficiency in Sport) panels measuring biomarkers for performance, recovery and hormonal balance.
- ForthConnect Business Platform Separate ForthConnect B2B platform (forthconnect.io) offering Forth's home blood tests as employee health testing and corporate wellness programs for UK organisations.
Quantifiable outcome
- 40.3% of women over 40 had female hormone health scores in the 'improvable' range (below 70)
- +4 more outcomes
Companies that use Forth
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Forth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Forth partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- NHS LaboratoriescoreAll Forth blood samples are analysed in NHS-accredited and UKAS-accredited laboratories, ensuring medical-grade accuracy and reliability comparable to NHS testing.
- Mobile Phlebotomy NetworkcoreNetwork of mobile phlebotomists and nurses who visit customer homes across the UK to collect venous blood samples for advanced tests requiring professional collection.
- Partner Clinic NetworkcoreOver 270 partner clinics across the UK where customers can book appointments for professional venous blood draw services.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Forth competitors and assessment
Company assessmentDirect peers
- myLAB Box: US-based at-home STI and wellness testing brand — relevant peer for Forth's sexual health suite and overall DTC home-testing model.
- Thriva: UK-based direct-to-consumer at-home blood testing brand offering finger-prick self-collection, app-based results, and personalised health insights — the most directly comparable competitor to Forth in the UK DTC diagnostics market.
- Medichecks: UK home blood testing service offering a broad catalogue of finger-prick and venous tests with clinician-reviewed results, overlapping directly with Forth's general health, hormone, and nutrition panels.
- YorkTest: Long-standing UK wellness-focused home testing brand (food intolerance, hormones, general health) targeting a similar proactive health consumer segment with postal sample collection and lab analysis.
- LetsGetChecked: Global at-home diagnostics platform offering finger-prick and venous tests including hormones, sexual health, and cancer screening — competing with Forth across most product categories with greater scale and capitalisation.
- Everlywell: US-headquartered D2C home testing brand with a broad hormone, STI, metabolic, and wellness portfolio — a near-analogous model though primarily serving North American customers.
- InsideTracker: Blood biomarker-based performance and longevity platform serving health-conscious and athletic consumers — closely comparable to Forth's sports and general health panels with AI-driven personalised recommendations.
Emerging players
- Paloma Health: Specialised thyroid-focused telehealth and home testing platform — an adjacent niche player relevant to Forth because it combines at-home blood testing with clinician consultation and female-hormone-adjacent disease areas.
- Daye: UK at-home vaginal health screening and tampon-based STI diagnostics — a fellow UK female-health consumer brand expanding the at-home testing category Forth also targets.
Regional players
- NHS Health Check: UK NHS-provided free cardiovascular risk assessment for 40-74 year olds — a public-sector baseline against which Forth's paid-for general wellness and cancer screening must compete on convenience, breadth, and depth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Forth social profiles
Digital presenceForth compliance and trust
Trust signalCompliance5 records
Forth financial estimates
Financial estimateRevenue estimate
Valuation estimate
Forth leadership team
Management profileNumber of profiles
Profiles6 records
Forth subsidiaries and ownership
Company hierarchySubsidiaries1 record
Forth funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Forth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Forth
What does Forth do?
Forth operates a direct-to-consumer home blood testing platform selling fingerprick and venous blood sample collection kits spanning female hormones, general wellness, nutrition, sexual health, sports performance, and cancer screening. Samples are analysed by UKAS-accredited laboratories and results are delivered through the HealthCoach mobile app with health scores and personalised recommendations, plus optional home phlebotomy and a 270+ partner-clinic network. A separate ForthConnect B2B channel serves corporate wellness programs.
Is Forth a public or private company?
Forth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Forth founded?
Forth was founded in 2016. It employs 1 to 10 people.
Where is Forth based?
Forth is headquartered in Chepstow, United Kingdom, in the Europe region.
How does Forth make money?
Three revenue lines are on record. Direct-to-Consumer Blood Tests are the primary driver. The others are truCheck Cancer Screening and bespoke Test Builder.
Who are Forth's main competitors?
Direct peers on record are myLAB Box, Thriva, Medichecks, YorkTest, LetsGetChecked, Everlywell and InsideTracker. Emerging players are Paloma Health and Daye. NHS Health Check is listed as a regional player.
Does Forth have an API?
No public API is recorded for Forth.
What industry is Forth in?
Forth's product category is Direct-to-consumer at-home blood testing. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 6215 and its SIC code is 2835.